In lots of myeloid and lymphoid malignancies, driver mutations resulting in constitutive JAK activation can be found. The paradigm is represented by BCR-ABL11. Cytokine binding induces or re-orients receptor dimerization, such that JAK kinase domains deal with each other inside of a effective conformation for transactivation and phosphorylation fro